共 8 条
[1]
Martinez L., de Letona J., Masa Vazquez C., Perez Maestu R., 2nd letter: Visceral leishmaniasis as an opportunistic infection, Lancet, 1, (1986)
[2]
Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixera R., Johnson W.D., New perspectives on a subclinical form of visceral leishmaniasis, J Infect Dis, 154, pp. 1003-1011, (1986)
[3]
Fernandez-Guerrero M., Aguado J., Buzon L., Barros C., Motalban C., Martin T., Bouza E., Visceral lesishmaniasis in immunocompromised hosts, The American Journal of Medicine, 83, pp. 1098-1102, (1987)
[4]
Chulay J.D., Bhatt S.M., Muigai R., Et al., A comparison of three dosage regimens of sodium stibogluconate in the treatment of viscerall leishmaniasis in Kenya, J Infect Dis, 148, pp. 148-155, (1983)
[5]
Carvalho E.M., Bacellar O., Barral A., Badaro R., Johnson W.D., Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated, J Clin Invest, 83, pp. 860-864, (1989)
[6]
Wallis P.J.W., Clark C.J.M., Visceral leishmaniasis complicating systemic lupus erythematosus, case report, Ann Rheum Dis, 42, pp. 201-202, (1983)
[7]
Cohen J., Pinching A.J., Rees A.J., Peters D.K., Infection and Immunosuppression, Q J Med, 201, pp. 1-15, (1982)
[8]
Neva F.A., Immunotherapy for parasitic disease (editorial), N Engl J Med, 322, pp. 55-57, (1990)

